Human epidermal growth factor receptor 2 (HER2) plays a vital role in tumorigenesis, invasion, and metastasis of breast cancer, leading to a poor prognosis and shorter survival (Slamon et al., 1989). This evidence concerns the gene ERBB2 and breast cancer.